Impulse Dynamics, a Marlton, N.J.-based company serving healthcare providers focused on people with heart failure, completed a $60m supplemental Series D crossover financing.
Backers included new investors anchored by CR-CCT Industry Pilot Fund together with Redmile Group and Perceptive Advisors.
Proceeds of the financing will be used for general corporate purposes, including acceleration of clinical and product development activities along with continued U.S. commercialization of the Optimizer® Smart
Impulse Dynamics has pioneered CCM® therapy, which is delivered by the company’s Optimizer® system, an FDA-approved implantable device for treating chronic heart failure that has been proven to strengthen the heart and help it beat more forcibly. It is implanted during a minimally invasive procedure while a patient is under light sedation and has been used to treat over 5,000 patients worldwide. It is currently available in the United States, Europe, China, Brazil, India and more than 40 other countries around the world.